Losartan Potassium & Hydrochlorothiazide Tablets recall: Impurity Out of Spec
Losartan Potassium & Hydrochlorothiazide Tablets, USP, 50 mg/12.5 mg, a) 30-count bottles (NDC# 33342-050-07), b) 90-count bottles (NDC #…
Why was Losartan Potassium & Hydrochlorothiazide Tablets recalled?
CGMP Deviations- AZIDO Impurity levels observed to be above acceptable limits
What should I do if I have this product?
Review the official FDA enforcement record for current instructions.
What to do with a recalled product: refunds, receipts, safe disposal and how to report a problem.
Is my product affected?
Compare the item in your hand with every identifier below from the official FDA record. Only products that match the listed product and lot, UPC or model codes are part of this recall.
Which lot codes, UPCs or models are affected?
Lot # BLK2107B, exp. date 05/2023 BLK2101A, exp. date 01/2025 BLK2102A, exp. date 02/2025 BLK2103B, exp. date 02/2023 BLK2103C, exp. date 02/2023 BLK2104A, exp. date 05/2023
- Product
- Losartan Potassium & Hydrochlorothiazide Tablets, USP, 50 mg/12.5 mg, a) 30-count bottles (NDC# 33342-050-07), b) 90-count bottles (NDC #…
- Recalling firm
- Macleods Pharma Usa Inc
- Quantity
- N/A
- Distribution
- Product was distributed nationwide.
- Recall date
- May 11, 2022
- Classification
- Class II
- Status
- Terminated
- Agency
- FDA (drug)